In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By



Latest From Pharmaxon

Recent Tech Transfer Deals (07/07)

Each month, Start-Up presents a survey of technology transfer deals--licensing agreements between companies and universities or other research institutions--in the fields of life sciences, including pharmaceuticals, medical devices, in vitro diagnostics and research/analytical instrumentation and reagents.

Recent Financings of Private Companies (12/2006)

Each month, Start-Up presents a comprehensive review of young, private life science companies that have recieved venture funding during the month, including companies in the pharmaceutical, medical device, diagnostic and research instrumentation & reagent sectors.

Selected Start-Ups (9/05)

In Vivo briefly summarizes the technologies of these recently founded companies: Cerenis Therapeutics, iBalance Medical, NABsys, Pharmaxon, Synthetic Genomics, Theraclion.
See All

Company Information

  • Industry
  • Biotechnology
  • Contract Research, Toxicology Testing-CRO
  • Pharmaceuticals
  • Therapeutic Areas
  • Cancer
  • Neurology, Nervous System
  • Alias(es)
  • Ownership
  • Private
  • Headquarters
  • Worldwide
    • Europe
      • Western Europe
        • France
  • Parent & Subsidiaries
  • Pharmaxon
  • Senior Management
  • Pascal Deschaseaux, MD, CEO
    Geneviève Rougon, PhD, CSO
  • Contact Info
  • Pharmaxon
    Phone: (33) 4 91 26 97 36
    IBDM-Campus de Luminy-Case 907
    Cedex 9
    Marseille, 13288